Journal Title：Blood And Lymphatic Cancer-targets And Therapy

Blood and lymphatic system cancers - targets and treatments "is a cutting-edge academic journal focused on research in the field of blood and lymphatic system cancers. With the global incidence rate of blood tumors (such as leukemia, lymphoma, etc.) rising year by year, the magazine came into being and is committed to promoting scientific research and clinical treatment progress in this field. Its published content covers various aspects of cancer, such as molecular mechanisms, novel therapeutic targets, innovative therapies, and clinical trials, providing researchers, clinical doctors, and patients with the latest scientific research achievements and diagnosis and treatment information. This magazine is published by authoritative institutions and undergoes rigorous peer review to ensure the scientific and reliable nature of its published content. As a professional journal in this field, 'Hematological and Lymphatic System Cancer - Targets and Treatment' plays an important role in promoting research and development in hematological oncology.

《血液和淋巴系統(tǒng)癌癥-靶點(diǎn)和治療》是一本專注于血液和淋巴系統(tǒng)癌癥領(lǐng)域研究的前沿學(xué)術(shù)期刊。隨著血液腫瘤（如白血病、淋巴瘤等）在全球范圍內(nèi)的發(fā)病率逐年上升，該雜志應(yīng)運(yùn)而生，致力于推動該領(lǐng)域的科學(xué)研究與臨床治療進(jìn)步。其發(fā)表內(nèi)容涵蓋癌癥的分子機(jī)制、新型治療靶點(diǎn)、創(chuàng)新療法及臨床試驗等各個方面，為研究者、臨床醫(yī)生和患者提供最新的科研成果和診療信息。該雜志由權(quán)威機(jī)構(gòu)出版，經(jīng)過嚴(yán)格的同行評審，確保了所發(fā)表內(nèi)容的科學(xué)性和可靠性。作為該領(lǐng)域的專業(yè)期刊，《血液和淋巴系統(tǒng)癌癥-靶點(diǎn)和治療》在推動血液腫瘤研究與發(fā)展方面發(fā)揮著重要作用。

Blood And Lymphatic Cancer-targets And Therapy由Dove Medical Press出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，平均審稿速度 16 Weeks ，影響因子指數(shù)3.9，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。